Jiangxi Fushine Pharmaceutical Co., Ltd.
SZSE:300497.SZ
10.05 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||
Net Income
| -223.256 | -164.175 | 39.538 | 322.179 | 306.88 | 192.362 | 174.477 | 172.52 | 93.602 | 53.441 | 45.073 | 40.079 | 0 |
Depreciation & Amortization
| 159.459 | 123.838 | 98.568 | 73.933 | 66.527 | 52.834 | 45.197 | 34.17 | 28.502 | 23.235 | 17.478 | 10.247 | 0 |
Deferred Income Tax
| -4.707 | -0.723 | -18.161 | -3.796 | 1.714 | -1.61 | 13.431 | -2.62 | -1.083 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 7.031 | 1.657 | 6.32 | 0 | 0.772 | 4.853 | 15.57 | 15.983 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -122.988 | -301.976 | -233.301 | -73.498 | -98.964 | -109.379 | -22.867 | -25.219 | -66.469 | -54.219 | -12.218 | -1.877 | 0 |
Accounts Receivables
| -159.446 | -273.946 | -199.386 | -152.728 | -149.721 | -92.825 | -36.89 | -26.813 | -39.336 | -26.094 | 3.846 | 0 | 0 |
Inventory
| 74.55 | -259.581 | -154.854 | -52.367 | -28.825 | -22.98 | -26.881 | -44.773 | 5.498 | -35.758 | -18.867 | 9.573 | 0 |
Accounts Payables
| -33.385 | 232.274 | 139.099 | 135.393 | 77.868 | 8.035 | 27.472 | 48.987 | -31.549 | 0 | 0 | 0 | 0 |
Other Working Capital
| 7.031 | -0.723 | -18.161 | -3.796 | 1.714 | -86.399 | 4.014 | 19.554 | -71.968 | -18.46 | 6.649 | -11.45 | 0 |
Other Non Cash Items
| 39.029 | 221.462 | 167.516 | 59.737 | 63.469 | 40.098 | 13.917 | 7.063 | 18.374 | 8.932 | 6.886 | 14.746 | 0 |
Operating Cash Flow
| -64.763 | -120.851 | 72.322 | 382.351 | 337.911 | 175.914 | 210.723 | 188.534 | 74.009 | 31.39 | 57.219 | 63.196 | 0 |
Investing Activities: | |||||||||||||
Investments In Property Plant And Equipment
| -242.225 | -459.411 | -679.597 | -449.237 | -324.901 | -163.887 | -98.995 | -81.336 | -73.744 | -51.862 | -75.6 | -51.243 | -82.212 |
Acquisitions Net
| 1.61 | 3.807 | 0.296 | 457.124 | 325.487 | -1.387 | -10.272 | 0.29 | 0.754 | 0 | 0 | -7.719 | -4 |
Purchases Of Investments
| -161.7 | -302.8 | -520.859 | -208.251 | -130 | -306.35 | -490 | -314 | 0 | 0 | 0 | 0.026 | 0.014 |
Sales Maturities Of Investments
| 47.813 | 250.069 | 448.478 | 101.1 | 102.863 | 310.186 | 537.881 | 141.997 | 0.328 | 0.91 | 0.89 | 0.884 | 0.645 |
Other Investing Activites
| -112.277 | 0 | 16.198 | -449.237 | -324.901 | 0 | 0.947 | 1.082 | 1.474 | 1.165 | 0.133 | -21.187 | 48.109 |
Investing Cash Flow
| -354.502 | -508.335 | -735.484 | -548.501 | -351.453 | -161.437 | -60.439 | -252.257 | -71.943 | -49.788 | -74.577 | -79.265 | -37.459 |
Financing Activities: | |||||||||||||
Debt Repayment
| -206.044 | -830.488 | -488.5 | -596.5 | -716.996 | -421.338 | -212.575 | -198.2 | -167.634 | -151.02 | -114.89 | -102.195 | -57.242 |
Common Stock Issued
| -0.377 | 72.944 | 105.113 | -1.159 | 96.918 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| -20.536 | -72.944 | -105.113 | 1.159 | -96.918 | -3.103 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -55.79 | -54.581 | -110.001 | -56.764 | -43.914 | -79.742 | -70.839 | -45.331 | -32.84 | -9.852 | -9.353 | -7.098 | -5.623 |
Other Financing Activities
| -0.489 | 1,168.056 | 977.29 | 1,591.087 | 826.313 | 670.828 | 370.688 | 272.345 | 491.402 | 176.94 | 139.457 | 140.105 | 84.789 |
Financing Cash Flow
| 149.765 | 282.987 | 349.611 | 912.691 | 30.818 | 169.748 | 87.274 | 28.814 | 290.928 | 16.068 | 15.213 | 30.812 | 21.923 |
Other Information: | |||||||||||||
Effect Of Forex Changes On Cash
| 3.003 | 9.51 | 0.737 | -8.603 | -0.005 | 4.378 | -3.083 | 3.698 | -0.031 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -266.497 | -336.689 | -312.815 | 737.937 | 17.271 | 188.603 | 234.476 | -31.21 | 292.962 | -2.33 | -2.145 | 14.743 | 18.262 |
Cash At End Of Period
| 580.755 | 847.253 | 1,183.942 | 1,496.756 | 758.819 | 741.548 | 552.945 | 318.469 | 349.679 | 56.717 | 59.047 | 61.192 | 46.449 |